Business Problem
Client is a leader in developing next-generation targeted therapies for oncology using a highly potent alpha-emitting radioisotope therapy. Their focus lies in addressing high unmet medical needs for cancer patients, particularly those unresponsive to existing therapies. The client aims to harness their targeted alpha therapy’s capacity for selective destruction of cancer cells while minimizing damage to healthy tissues.
The client faced multiple challenges as they expanded operations
Limited Radioisotope Supply:
- Scarcity of supply slowed progress in scaling targeted alpha therapies.
High Employee Turnover:
- Increased recruitment and training costs were hindering operations, particularly in their specialized radioisotope-focused research.
Expansion Goals:
- The client needed a staffing partner to quickly provide qualified candidates for their growing 11,000-square-foot facility and complex research operations